Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1962 1
1963 1
1964 1
1965 3
1967 3
1968 2
1969 1
1970 1
1972 1
1974 1
1975 4
1976 4
1977 2
1978 3
1979 5
1980 1
1981 4
1982 3
1983 7
1984 12
1985 9
1986 8
1987 6
1988 11
1989 16
1990 6
1991 11
1992 22
1993 21
1994 18
1995 20
1996 20
1997 22
1998 24
1999 29
2000 37
2001 27
2002 31
2003 41
2004 41
2005 50
2006 61
2007 67
2008 78
2009 100
2010 113
2011 117
2012 143
2013 175
2014 285
2015 321
2016 380
2017 411
2018 470
2019 504
2020 583
2021 691
2022 746
2023 756
2024 330

Text availability

Article attribute

Article type

Publication date

Search Results

6,028 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
Voorhees PM, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Costa LJ, Anderson LD Jr, Nathwani N, Shah N, Efebera YA, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Orlowski RZ, Shain KH, Cowan AJ, Murphy S, Lutska Y, Pei H, Ukropec J, Vermeulen J, de Boer C, Hoehn D, Lin TS, Richardson PG. Voorhees PM, et al. Among authors: shah n. Blood. 2020 Aug 20;136(8):936-945. doi: 10.1182/blood.2020005288. Blood. 2020. PMID: 32325490 Free PMC article. Clinical Trial.
Patients (N = 207) were randomized 1:1 to D-RVd or RVd induction (4 cycles), ASCT, D-RVd or RVd consolidation (2 cycles), and lenalidomide or lenalidomide plus D maintenance (26 cycles). ...Median CD34+ cell yield was 8.2 106/kg for D-RVd and 9.4 106/k …
Patients (N = 207) were randomized 1:1 to D-RVd or RVd induction (4 cycles), ASCT, D-RVd or RVd consolidation (2 cycles), and …
The Risks and Benefits of Myopia Control.
Bullimore MA, Ritchey ER, Shah S, Leveziel N, Bourne RRA, Flitcroft DI. Bullimore MA, et al. Among authors: shah s. Ophthalmology. 2021 Nov;128(11):1561-1579. doi: 10.1016/j.ophtha.2021.04.032. Epub 2021 May 4. Ophthalmology. 2021. PMID: 33961969 Free article. Review.
The article analyzes whether the potential benefits of slowing myopia progression by 1 diopter (D) justify the potential risks associated with treatments. METHODS: First, the known risks associated with various methods of myopia control are summarized, with emphasis on con …
The article analyzes whether the potential benefits of slowing myopia progression by 1 diopter (D) justify the potential risks associ …
Indian Academy of Pediatrics Revised (2021) Guidelines on Prevention and Treatment of Vitamin D Deficiency and Rickets.
Gupta P, Dabas A, Seth A, Bhatia VL, Khadgawat R, Kumar P, Balasubramanian S, Khadilkar V, Mallikarjuna HB, Godbole T, Krishnamurthy S, Goyal JP, Bhakhri BK, Ahmad A, Angadi K, Basavaraj GV, Parekh BJ, Kurpad A, Marwaha RK, Shah D, Munns C, Sachdev HPS. Gupta P, et al. Among authors: shah d. Indian Pediatr. 2022 Feb 15;59(2):142-158. Epub 2021 Dec 29. Indian Pediatr. 2022. PMID: 34969941 Free article.
OBJECTIVES: To review the emerging literature on vitamin D prevalence and need for universal vitamin D supplementation. To suggest optimum vitamin D therapy for treatment of asymptomatic and symptomatic vitamin D deficiency, and rickets. ...
OBJECTIVES: To review the emerging literature on vitamin D prevalence and need for universal vitamin D supplementation. To sug …
Does vitamin D supplementation reduce COVID-19 severity?: a systematic review.
Shah K, Varna VP, Sharma U, Mavalankar D. Shah K, et al. QJM. 2022 Oct 25;115(10):665-672. doi: 10.1093/qjmed/hcac040. QJM. 2022. PMID: 35166850 Free PMC article.
BACKGROUND: The evidence regarding the efficacy of vitamin D supplementation in reducing severity of COVID-19 is still insufficient. ...Hence, vitamin D should be recommended as an adjuvant therapy for COVID-19.However, more robust and larger trials are required to …
BACKGROUND: The evidence regarding the efficacy of vitamin D supplementation in reducing severity of COVID-19 is still insufficient. …
Interventions for myopia control in children: a living systematic review and network meta-analysis.
Lawrenson JG, Shah R, Huntjens B, Downie LE, Virgili G, Dhakal R, Verkicharla PK, Li D, Mavi S, Kernohan A, Li T, Walline JJ. Lawrenson JG, et al. Among authors: shah r. Cochrane Database Syst Rev. 2023 Feb 16;2(2):CD014758. doi: 10.1002/14651858.CD014758.pub2. Cochrane Database Syst Rev. 2023. PMID: 36809645 Free PMC article. Review.
At one year, in 38 studies (6525 participants analysed), the median change in SER for controls was -0.65 D. The following interventions may reduce SER progression compared to controls: HDA (mean difference (MD) 0.90 D, 95% confidence interval (CI) 0.62 to 1.18), MDA …
At one year, in 38 studies (6525 participants analysed), the median change in SER for controls was -0.65 D. The following interventio …
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth.
Roth DE, Morris SK, Zlotkin S, Gernand AD, Ahmed T, Shanta SS, Papp E, Korsiak J, Shi J, Islam MM, Jahan I, Keya FK, Willan AR, Weksberg R, Mohsin M, Rahman QS, Shah PS, Murphy KE, Stimec J, Pell LG, Qamar H, Al Mahmud A. Roth DE, et al. Among authors: shah ps. N Engl J Med. 2018 Aug 9;379(6):535-546. doi: 10.1056/NEJMoa1800927. N Engl J Med. 2018. PMID: 30089075 Free PMC article. Clinical Trial.
BACKGROUND: It is unclear whether maternal vitamin D supplementation during pregnancy and lactation improves fetal and infant growth in regions where vitamin D deficiency is common. ...CONCLUSIONS: In a population with widespread prenatal vitamin D deficiency …
BACKGROUND: It is unclear whether maternal vitamin D supplementation during pregnancy and lactation improves fetal and infant growth …
Genome-wide Association Study for Vitamin D Levels Reveals 69 Independent Loci.
Manousaki D, Mitchell R, Dudding T, Haworth S, Harroud A, Forgetta V, Shah RL, Luan J, Langenberg C, Timpson NJ, Richards JB. Manousaki D, et al. Among authors: shah rl. Am J Hum Genet. 2020 Mar 5;106(3):327-337. doi: 10.1016/j.ajhg.2020.01.017. Epub 2020 Feb 13. Am J Hum Genet. 2020. PMID: 32059762 Free PMC article.
We aimed to increase our understanding of the genetic determinants of vitamin D levels by undertaking a large-scale genome-wide association study (GWAS) of serum 25 hydroxyvitamin D (25OHD). ...Therefore, through a large 25OHD GWAS, we identified 63 loci that underl …
We aimed to increase our understanding of the genetic determinants of vitamin D levels by undertaking a large-scale genome-wide assoc …
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials.
Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, Bergman P, Bischoff-Ferrari HA, Borzutzky A, Damsgaard CT, Dubnov-Raz G, Esposito S, Gilham C, Ginde AA, Golan-Tripto I, Goodall EC, Grant CC, Griffiths CJ, Hibbs AM, Janssens W, Khadilkar AV, Laaksi I, Lee MT, Loeb M, Maguire JL, Majak P, Mauger DT, Manaseki-Holland S, Murdoch DR, Nakashima A, Neale RE, Pham H, Rake C, Rees JR, Rosendahl J, Scragg R, Shah D, Shimizu Y, Simpson-Yap S, Trilok-Kumar G, Urashima M, Martineau AR. Jolliffe DA, et al. Among authors: shah d. Lancet Diabetes Endocrinol. 2021 May;9(5):276-292. doi: 10.1016/S2213-8587(21)00051-6. Epub 2021 Mar 30. Lancet Diabetes Endocrinol. 2021. PMID: 33798465
METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, Web of Science, and the ClinicalTrials.gov registry for studies listed from database inception to May 1, 2020. Double-blind RCTs of vitamin D …
METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, Web …
Vitamin D Therapy in Adults With CKD: A Systematic Review and Meta-analysis.
Yeung WG, Palmer SC, Strippoli GFM, Talbot B, Shah N, Hawley CM, Toussaint ND, Badve SV. Yeung WG, et al. Among authors: shah n. Am J Kidney Dis. 2023 Nov;82(5):543-558. doi: 10.1053/j.ajkd.2023.04.003. Epub 2023 Jun 24. Am J Kidney Dis. 2023. PMID: 37356648
RATIONALE & OBJECTIVE: Vitamin D is widely used to manage chronic kidney disease-mineral and bone disorder (CKD-MBD). ...We found that vitamin D therapy affects serum biomarkers, including an increase in serum calcium. ...
RATIONALE & OBJECTIVE: Vitamin D is widely used to manage chronic kidney disease-mineral and bone disorder (CKD-MBD). ...We found …
Overminus Lens Therapy for Children 3 to 10 Years of Age With Intermittent Exotropia: A Randomized Clinical Trial.
Chen AM, Erzurum SA, Chandler DL, Hercinovic A, Melia BM, Bhatt AR, Suh DW, Vricella M, Erickson JW, Miller AM, Marsh JD, Bodack MI, Martinson SR, Titelbaum JR, Gray ME, Holtorf HL, Kong L, Kraker RT, Rahmani B, Shah BK, Holmes JM, Cotter SA; Pediatric Eye Disease Investigator Group. Chen AM, et al. Among authors: shah bk. JAMA Ophthalmol. 2021 Apr 1;139(4):464-476. doi: 10.1001/jamaophthalmol.2021.0082. JAMA Ophthalmol. 2021. PMID: 33662112 Free PMC article. Clinical Trial.
INTERVENTIONS: Participants were randomly assigned to overminus spectacle therapy (-2.50 D for 12 months, then -1.25 D for 3 months, followed by nonoverminus spectacles for 3 months) or to nonoverminus spectacle use. ...Myopic shift from baseline to 12 months was gr …
INTERVENTIONS: Participants were randomly assigned to overminus spectacle therapy (-2.50 D for 12 months, then -1.25 D for 3 m …
6,028 results